Oracle Corp (NYSE:ORCL) shares are trading higher on Wednesday as the company recently disclosed that it is expanding its cloud offerings through a multi-year deal with Quantinuum (NASDAQ:QNT).

This collaboration will bring Helios quantum computing to Oracle Cloud, enhancing its GPU and high-performance computing infrastructure.

Oracle-Quantinuum Deal Expands Quantum Computing On Oracle Cloud

The partnership with Quantinuum signifies Oracle’s commitment to advancing its cloud capabilities, particularly in quantum computing, which is expected to play a crucial role in future technology landscapes.

This deal aligns with Oracle’s ongoing efforts to innovate and stay competitive in the rapidly evolving tech market.

Read Also: AI Hyperscaler Spending Is Entering Uncharted Territory: 3x the Telecom Boom

New AI Agents For HR

Apart from this, Oracle recently disclosed new Fusion Agentic Applications and AI agents for HR designed to help businesses enhance workforce development, improve internal mobility and address evolving skills requirements. Built into Oracle Fusion Cloud Applications, the tools use coordinated, specialized AI agents to proactively reason, make decisions and execute tasks within business workflows using secure access to enterprise data, policies, permissions and transaction details.

Also, Oracle said that its AI-powered Health Patient Portal is now generally available in the U.S., combining a consumer-friendly interface with secure integration into Oracle Health’s EHR. The platform lets patients review and share medical records, connect with providers, and manage their care, while also providing plain-language explanations of diagnoses, test results and treatment options.

ORCL Technical Outlook: Key Support, Resistance And Momentum

Oracle’s current price of $149.69 is 12.7% above its 20-day simple moving average (SMA) of $132.16, suggesting a bullish short-term trend. However, the stock remains 4.3% below its 50-day SMA of $155.65, indicating potential resistance at this level.

The Relative Strength Index (RSI) is currently at 54.26, reflecting a neutral momentum position, suggesting that the stock is neither overbought nor oversold. This neutral stance allows for further price movement without immediate concerns of a reversal.

  • Key Resistance: $149.00 — a nearby level where rebounds can stall.
  • Key Support: $135.00 — a nearby level where buyers previously stepped in.

Oracle Earnings Preview And Analyst Price Targets

Oracle is slated to provide its next financial update on September 8, 2026 (estimated).

  • EPS Estimate: $1.67 (Up from $1.47)
  • Revenue Estimate: $19.13 billion (Up from $14.93 billion)
  • Valuation: P/E of 25.0x (Indicates fair valuation)

Analyst Consensus & Recent Actions: The stock carries a Buy rating with an average price forecast of $258.50. Recent analyst moves include:

  • UBS: Buy (Lowers Target to $245.00) (August 6)
  • CLSA: Initiated with Hold (Target $145.00) (July 20)
  • Bernstein: Outperform (Raises Target to $325.00) (June 11)

How Oracle Ranks On Value, Growth And Momentum

Below is the Benzinga Edge scorecard for Oracle, highlighting its strengths and weaknesses compared to the broader market:

  • Value: Weak (Score: 19.27) — Trading at a steep premium relative to peers.
  • Growth: Strong (Score: 95.29) — Indicates robust growth potential.
  • Momentum: Weak (Score: 6.34) — Stock is underperforming the broader market.

The Verdict: Oracle’s Benzinga Edge signal reveals a growth-heavy profile, indicating strong potential for expansion despite current momentum challenges. The weak value score suggests that the stock may be trading at a premium, which could warrant caution for value-focused investors.

Top ETFs Holding Oracle Stock And Why It Matters

  • iShares Expanded Tech-Software Sector ETF (BATS:IGV): 5.87% Weight
  • First Trust Dow Jones Internet Index Fund (NYSE:FDN): 4.30% Weight
  • First Trust NASDAQ Technology Dividend Index Fund (NASDAQ:TDIV): 5.21% Weight

Significance: Because ORCL carries such a heavy weight in these funds, any significant inflows or outflows for these ETFs will likely force automatic buying or selling of the stock.

ORCL Price Action: Oracle shares were up 2.50% to $149.11 at the time of publication on Wednesday, according to Benzinga Pro data.

Photo via Shutterstock